These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24876755)

  • 1. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
    Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
    World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
    Wang DR; Tang D
    World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
    Sui C; Wang G; Chen Q; Ma J
    Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of SRY-Box 21 (
    Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
    Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
    Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
    Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
    Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
    Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
    Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wif-1 methylation and β-catenin expression in colorectal serrated lesions].
    Fang Y; Wang L; Zhang Y; Ge C; Xu C
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):15-9. PubMed ID: 24713243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
    Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
    BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
    Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
    Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.
    Amiot A; Mansour H; Baumgaertner I; Delchier JC; Tournigand C; Furet JP; Carrau JP; Canoui-Poitrine F; Sobhani I;
    PLoS One; 2014; 9(7):e99233. PubMed ID: 25025467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variation trends of SFRP2 methylation of tissue, feces, and blood detection in colorectal cancer development.
    Sui C; Ma J; Chen Q; Yang Y
    Eur J Cancer Prev; 2016 Jul; 25(4):288-98. PubMed ID: 26258809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.